Skip navigation
|
Contact Us
[
Viewing Options
]
Search this site
Home
Hepatitis C
The Liver & Hepatitis C
Living with Hepatitis C
Treatment
Wellness
Support
Hepatitis C Trust
News
News
News
2008
2007
December
November
October
September
August
July
June
May
April
Business Articles on VX950
Charity manager jailed for theft
Contaminated blood inquiry begins
Film follows life of Hepatitis C sufferer
Hepatitis A And Hepatitis C Attack Same Protein To Block Immune Defenses, Scientists Find
Live presentation on VX950 from EASL 2007
New Zealand - First One-Off Payments Offered
Phynova sees at least 3 products in clinical trials by year-end
Protein Found That Slows Hepatitis C Growth In Liver Cells
Tests of clotting agent 'led to 2,000 deaths'
The Guardian - Widow accuses doctors over donor blood risks
US liver center leading record number of studies to tackle hepatitis C
VX950 - Interim Results Presented at EASL from PROVE 1 Clinical Trial
March
February
January
2006
2005
2004
Print this page
Email to a friend
Comment on this page
Link to this page
Add page to favourites
News
>
2007
>
April
April
Last updated:13August2007
Business Articles on VX950
Charity manager jailed for theft
Contaminated blood inquiry begins
Film follows life of Hepatitis C sufferer
Hepatitis A And Hepatitis C Attack Same Protein To Block Immune Defenses, Scientists Find
Live presentation on VX950 from EASL 2007
New Zealand - First One-Off Payments Offered
Phynova sees at least 3 products in clinical trials by year-end
Protein Found That Slows Hepatitis C Growth In Liver Cells
Tests of clotting agent 'led to 2,000 deaths'
The Guardian - Widow accuses doctors over donor blood risks
US liver center leading record number of studies to tackle hepatitis C
VX950 - Interim Results Presented at EASL from PROVE 1 Clinical Trial
[
Sign In
]
[
Sign Up
]
